cancer that has spread and is incurable , known as secondary breast cancer , kills 1,000 women in britain every month thousands . researchers of from women manchester whose university breast working cancer with has drug become development resistant company to evgen standard pharma treatment , could have benefit developed from a new drug combination . it targets cancer cells that evade of conventional drugs and which cause could tumours overcome to this re problem grow . cancer that has spread and is incurable , thousands known of as women secondary whose breast cancer , kills 1,000 women has in become britain resistant every to month standard . treatment it could is benefit hoped from the a new approach will target cancer stem cells that evade conventional drugs and cause the tumour to re drug grow combination . conventional drugs and cause the tumour to re grow . 